Skip to main content Accessibility help
×
Home
  • Print publication year: 2014
  • Online publication date: October 2014

Chapter 9 - Acute and subacute ataxia

References

1. GrimaldiG, MantoM. (2012). Topography of cerebellar deficits in humans. Cerebellum 11: 336–351.
2. AmarencoP. (1991). The spectrum of cerebellar infarctions. Neurology 41: 973–979.
3. MascalchiM, FilippiM, FlorisR, et al. (2005). Diffusion-weighted MR of the brain: methodology and clinical application. Radiol Med 109: 155–197.
4. MoulinT, BogousslavskyJ, ChopardJL, et al. (1995). Vascular ataxic hemiparesis: a re-evaluation. J Neurol Neurosurg Psychiatry 58: 422–427.
5. Newman-TokerDE, KattahJC, AlverniaJE, WangDZ. (2008). Normal head impulse test differentiates acute cerebellar strokes from vestibular neuritis. Neurology 70: 2378–2385.
6. LeeH, SohnSI, ChoYW, et al. (2006). Cerebellar infarction presenting isolated vertigo: frequency and vascular topographical patterns. Neurology 67: 1178–1183.
7. MoonIS, KimJS, ChoiKD, et al. (2009). Isolated nodular infarction. Stroke 40: 487–491.
8. KirmaniJF, AlkawiA, PanezaiS, GizziM. (2012). Advances in thrombolytics for treatment of acute ischemic stroke. Neurology 79: S119–S125.
9. St LouisEK, WijdicksEF, LiH, AtkinsonJD. (2000). Predictors of poor outcome in patients with a spontaneous cerebellar hematoma. Can J Neurol Sci 27: 32–36.
10. SatohH. (2000). Occupational and environmental toxicology of mercury and its compounds. Ind Health 38: 153–164.
11. KorogiY, TakahashiM, OkajimaT, EtoK. (1998). MR findings of Minamata disease – organic mercury poisoning. J Magn Reson Imaging 8: 308–316.
12. KuruvillaT, BharuchaNE. (1997). Cerebellar atrophy after acute phenytoin intoxication. Epilepsia 38: 500–502.
13. RoyM, StipE, BlackD, LewV, LangloisR. (1998). Cerebellar degeneration following acute lithium intoxication. Rev Neurol (Paris) 154: 546–548.
14. SuwanlaongK, PhanthumchindaK (2008). Neurological manifestation of methyl bromide intoxication. J Med Assoc Thai 91: 421–426.
15. XiaoL, LinX, CaoJ, WangX, WuL (2011). MRI findings in 6 cases of children by inadvertent ingestion of diphenoxylate-atropine. Eur J Radiol 79: 432–436.
16. BoulosMI, ShoamaneshA, AvivRI, GladstoneDJ, SwartzRH (2012). Severe hypomagnesemia associated with reversible subacute ataxia and cerebellar hyperintensities on MRI. Neurologist 18: 223–225.
17. SedehizadehS, KeoghM, WillsAJ (2011). Reversible hypomagnesaemia-induced subacute cerebellar syndrome. Biol Trace Elem Res 142: 127–129.
18. NguyenHV, GanSK (2005). Neurological sequelae of chronic profound hypocalcaemia. Med J Aust 182: 123.
19. AsokumarP, GogateYV, GangadharP, BhansaliA (2011). Reversible cerebellar ataxia: a rare presentation of depletional hyponatremia. Neurol India 59: 631–632.
20. MascalchiM, SimonelliP, TessaC, et al. (1999). Do acute lesions of Wernicke’s encephalopathy show contrast enhancement? Report of three cases and review of the literature. Neuroradiology 41: 249–254.
21. ZuccoliG, PipitoneN (2009). Neuroimaging findings in acute Wernicke’s encephalopathy: review of the literature. AJR Am J Roentgenol 192: 501–508.
22. ZuccoliG, SantaCD, BertoliniM, et al. (2009). MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol 30: 171–176.
23. SechiG, SerraA (2007). Wernicke’s encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 6: 442–455.
24. NakagawaH, YonedaM, FujiiA, KinomotoK, KuriyamaM (2007). Hashimoto’s encephalopathy presenting with progressive cerebellar ataxia. J Neurol Neurosurg Psychiatry 78: 196–197.
25. TangY, ChuC, LinMT, et al. (2011). Hashimoto’s encephalopathy mimicking spinocerebellar ataxia. J.Neurol 258: 1705–1707.
26. FerracciF, BertiatoG, MorettoG (2004). Hashimoto’s encephalopathy: epidemiologic data and pathogenetic considerations. J Neurol Sci 217: 165–168.
27. CastilloP, WoodruffB, CaselliR, et al. (2006). Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol 63: 197–202.
28. BiottiD, DeschampsR, ShotarE, et al. (2011). CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Pract Neurol 11: 349–351.
29. PittockSJ, DebruyneJ, KreckeKN, et al. (2010). Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain 133: 2626–2634.
30. SimonNG, ParrattJD, BarnettMH, et al. (2012). Expanding the clinical, radiological and neuropathological phenotype of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). J Neurol Neurosurg Psychiatry 83: 15–22.
31. ScaglioneC, SalviF, RiguzziP, et al. (2001). Symptomatic unruptured capillary telangiectasia of the brain stem: report of three cases and review of the literature. J Neurol Neurosurg Psychiatry 71: 390–393.
32. OdakaM, YukiN, YamadaM, et al. (2003). Bickerstaff’s brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain–Barré syndrome. Brain 126: 2279–2290.
33. ShahrizailaN, YukiN (2012). Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. J Neurol Neurosurg Psychiatry 84: 576–583
34. MoragasM, Martinez-YelamosS, MajosC, et al. (2011). Rhombencephalitis: a series of 97 patients. Medicine (Baltimore) 90: 256–261.
35. MrowkaM, GrafLP, OdinP (2002). MRI findings in mesenrhombencephalitis due to Listeria monocytogenes. J Neurol Neurosurg Psychiatry 73: 775.
36. ArmstrongRW, FungPC (1993). Brainstem encephalitis (rhombencephalitis) due to Listeria monocytogenes: case report and review. Clin Infect Dis 16: 689–702.
37. GuerriniL, BelliG, CelleriniM, NenciniP, MascalchiM (2002). Proton MR spectroscopy of cerebellitis. Magn Reson Imaging 20: 619–622.
38. KlockgetherT, DollerG, WullnerU, PetersenD, DichgansJ (1993). Cerebellar encephalitis in adults. J Neurol 240: 17–20.
39. ZulianiL, GrausF, GiomettoB, BienC, VincentA (2012). Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J Neurol Neurosurg Psychiatry 83: 638–645.
40. SchlakeHP, HusstedtIW, GrotemeyerKH, PotterR (1989). Paraneoplastic subacute cerebellar degeneration in Hodgkin’s disease. Report of three cases and review of the literature. Clin Neurol Neurosurg 91: 329–335.
41. GilmoreCP, ElliottI, AuerD, MaddisonP (2010). Diffuse cerebellar MR imaging changes in anti-Yo positive paraneoplastic cerebellar degeneration. J Neurol 257: 490–491.
42. BasuS, AlaviA (2008). Role of FDG PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET–MRI correlates. Mol Imaging Biol 10:131–137.
43. GozzardP, MaddisonP (2010). Which antibody and which cancer in which paraneoplastic syndromes?Pract Neurol 10: 260–270.
44. Shams’iliS, GrefkensJ, de LB, et al. (2003). Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 126: 1409–1418.
45. SaizA, BlancoY, SabaterL, et al. (2008). Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131: 2553–2563.
46. HonnoratJ, SaizA, GiomettoB, et al. (2001). Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol 58: 225–230.
47. HoftbergerR, SabaterL, OrtegaA, DalmauJ, GrausF (2013). Patient with Homer-3 antibodies and cerebellitis. JAMA Neurol 70: 506–509.
48. BeckerEB, ZulianiL, PettingillR, et al. (2012). Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia. J Neurol Neurosurg Psychiatry 83: 437–440.
49. CooperSA, MurrayKL, HeathCA, WillRG, KnightRS (2006). Sporadic Creutzfeldt–Jakob disease with cerebellar ataxia at onset in the UK. J Neurol Neurosurg Psychiatry 77: 1273–1275.
50. JohnsonRT (2005). Prion diseases. Lancet Neurol 4: 635–642.
51. NeweyCR, SarwalA, WiscoD, AlamS, LedermanRJ (2013). Variability in diagnosing Creutzfeldt–Jakob disease using standard and proposed diagnostic criteria. J Neuroimaging 23: 58–63.
52. HamlinC, PuotiG, BerriS, et al. (2012). A comparison of tau and 14–3–3 protein in the diagnosis of Creutzfeldt–Jakob disease. Neurology 79: 547–552.
53. LahiriRP, BurnandKM, BandiA, FarooqN, Sathesh-KumarT (2011). Colorectal cancer presenting with dysarthria and ataxia: a case of isolated leptomeningeal metastasis. Ann R Coll Surg Engl 93: e133–e135.
54. YatesJW, ChalmerB, McKegneyFP (1980). Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45: 2220–2224.